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Flow cytometry assayl, rotavirus (RV) and Tetanus toxin (TT)memory B cells (mBc) in healthy adults using a
limitingdilutionassay (LDA)andaﬂowcytometryassay (FCA) that permitevaluationof bothCD27+andCD27−mBc.
RVmBcwere enriched in the CD27−, IgG+ and in the CD27+, IgM+ subsets. The numbers of RVmBcwere higher
by FCA than by LDA and results of the two assays did not correlate. TT IgGmBc and RV IgAmBc determined by FCA
and by LDA correlatedwith TT plasma IgG and RV plasma IgA, respectively. Themean ratio of speciﬁcmBc/μg/ml of
the corresponding plasma immunoglobulin was lower for TT IgG than for RV IgA mBc.
Our studies contribute to understand the relationship between circulating mBc and serological memory, and
enhance our capacity to develop better correlates of protection against RV disease.
© 2008 Elsevier Inc. All rights reserved.IntroductionRotavirus (RV) is the principal etiological agent of severe gastro-
enteritis (GE) in young children worldwide (Parashar et al., 2006).
Despite their preferential replication in the intestine, RV induces both
an intestinal and systemic immune response, the latter most probably
related to the antigenemia and viremia present in acutely infected
children and animals (Blutt and Conner, 2007; Blutt et al., 2007). The
RV-serum IgA titer, measured shortly after natural infection or oral
vaccination, is a relatively good correlate of protection (Angel et al.,
2007; Franco et al., 2006). However, our understanding of immunity
induced by different RV vaccines is poor and, in general, good cor-
relates of protection following vaccination have not been found (Angel
et al., 2007; Franco et al., 2006; Rojas et al., 2007). As part of an effort
to identify better correlates of protection for RV vaccines, we and
others have developed a ﬂow cytometry assay (FCA) to quantify and
characterize RV-speciﬁc B cells in mice (Feng et al., 2006; Youngman
et al., 2002), and naturally infected and vaccinated children (Gonzalez
et al., 2003; Jaimes et al., 2004; Parez et al., 2004; Weitkamp et al.,
2005). Using this assay, RV binding B cells seem to be a unique subset:
as expected, shortly after acute RV infection a fraction of RV-memory B
cells (mBc) express intestinal homing receptors (Jaimes et al., 2004).
Moreover, it was recently shown that VP6 RV protein interactsBc, memory B cell; TT, tetanus
try assay.
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l rights reserved.speciﬁcally with a large fraction of naive B cells (CD27−) from both
adults and neonates (Parez et al., 2004). The naive and mBc that bind
RV VP6 predominantly express the VH1–46 gene segment and are
enriched in the CD27+, IgD+, IgM+, subset (Tian et al., 2008).
A thorough understanding of the frequencies of antigen speciﬁc
mBc subsets and their relationship with the antibodies in serum
(serological memory) is likely to be critical to identify useful correlates
of protection for vaccines (Hofer et al., 2006; Lanzavecchia et al., 2006;
Nanan et al., 2001; Sasaki et al., 2007). Using tetanus toxin (TT) as a
model antigen, the number of speciﬁc mBc have correlatedwith some,
but not other, speciﬁc serum TT antibody concentrations, depending
on the types of assays used. Using a functional assay, in which blood
lymphocytes were stimulated polyclonally and TT-speciﬁc mBc were
quantiﬁed by limiting dilution assay (LDA), this correlation was found
(Bernasconi et al., 2002; Lanzavecchia et al., 2006). On the other hand,
the quantity of TT mBc, measured by a FCA similar to the one we have
previously used for RV mBc, did not correlate with the levels of serum
TT-speciﬁc IgG (Leyendeckers et al., 1999).
The purpose of the present study was to quantify and compare the
frequencies of circulating RV IgM, IgG and IgA mBc using LDA and FCA
in healthy adults, and to establish if there was a correlation between
the numbers of RV-speciﬁc IgG and IgAmBc, detected by eachmethod,
and the corresponding plasma RV antibody levels. For comparison,
total (non antigen speciﬁc) and TT-speciﬁc mBc levels were evaluated.
Results
Frequencies of total and antigen speciﬁc mBc measured by LDA
To determine the most sensitive method to evaluate RV-speciﬁc
mBc by LDA, we ﬁrst compared the frequency of these mBc detected
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protocols (Amanna and Slifka, 2006; Bernasconi et al., 2002; Crotty et
al., 2004), or minor variants of these protocols described in Materials
and methods. As shown in Fig. 1a, the number of RV-speciﬁc IgM/IgG/
IgA mBc detected in PBMC stimulated with CpG and IL-2 were higher
or comparable to those obtained with the other methods. We thus
selected the IL-2 and CpG stimulation of PBMC to determine the
frequency of circulating total, TT and RV-speciﬁc mBc by LDA. Fig. 1b
shows an example of these experiments. Less than 199 total antibody
producing B cells per 106 B cells were present in unstimulated PBMC.
Results for individual volunteers and median frequency of total and
antigen speciﬁc IgM, IgG and IgA mBc are reported in Fig. 2. The
frequency of total IgG and RV IgG mBc detected by LDA was higher
than that of total IgM and RV IgM mBc (Wilcoxon, pb0.017). In
contrast, the TT IgM mBc detected by LDA were more frequent than
the TT IgG mBc (Wilcoxon, p=0.012). Thus, using LDA, most total mBc
seem to bear the IgG isotype, but for individual antigen speciﬁc mBc
either IgG (RV) or IgM (TT) can be the predominant isotype.
Frequencies of total and antigen speciﬁc mBc measured by FCA
To evaluate the frequency of total and antigen speciﬁc mBc
detected by FCA, we puriﬁed CD19+ B cells with microbeads andFig. 1. (a) Higher or comparable numbers of RV IgM/IgG/IgA mBc were detected in CpG+
or puriﬁed B cells (ﬁlled symbols) were polyclonally stimulated with CpG+IL-2 (circles), CpG
10+NIH/3T3 murine ﬁbroblasts as feeder cells (stars). Speciﬁc mBc precursors were detected
MannWhitney test pb0.05. (b) Representative LDA experiments to determine total, TT and RV
andmethods. mBc frequencies were calculated from the 37% intercept. Correlation coefﬁcien
of the assay.stained themwith antibodies against CD20 (a marker of B cells, except
ASC), CD27 (a marker of most (Klein et al., 1998) but not all mBc
(Fecteau et al., 2006; Wirths and Lanzavecchia, 2005)) and IgM, IgG or
IgA to identify different isotypes of mBc. To recognize RVmBc we used
ﬂuorescent RV VLPs (Jaimes et al., 2004; Rojas et al., 2007; Youngman
et al., 2002) and to detect TT mBc we used biotinylated TT followed by
labeled streptavidin (Amanna and Slifka, 2006). For analysis, we
considered both the CD27+, IgM, IgG or IgA classically described mBc
(Klein et al., 1998) and the more recently described CD27−, IgG or IgA
mBc (Fecteau et al., 2006; Wirths and Lanzavecchia, 2005). Fig. 3
shows a representative FCA experiment to evaluate CD20+, CD27+
(Fig. 3a) and CD20+, CD27− (Fig 3b), naive and mBc.
Results of IgM, IgG and IgA mBc from all volunteers, detected by
FCA (the sum of CD27+ and CD27− subpopulations), are summarized
in Fig. 2, where they are compared to the results obtained with
the LDA. In contrast with the results by LDA, the median total, TT
and RV IgG mBc measured by FCA tended (Wilcoxon, pN0.1) to be
slightly lower than their respective IgM mBc. The frequencies of
total IgG, IgM and IgA, TT-speciﬁc IgG and RV-speciﬁc IgM, IgG and
IgA mBc were higher by FCA than by LDA (Wilcoxon pb0.03) (Fig.
2). This difference seems especially important for IgA mBc and
future studies are necessary to establish if conditions other than
those used in Fig. 1a will improve the efﬁciency of the LDA for theseIL-2 stimulated PBMC than with other stimulation methods. PBMCs (empty symbols)
+SAC+PWM (triangles), CpG+IL-2+ autologous CD4+ T cells (diamonds) or CpG+IL-2/6/
by ELISA after 10 days of culture. Bars represent the median. ⁎Statistical differences by
-speciﬁc mBc in PBMC polyclonally stimulatedwith CpG+IL-2, as described inMaterials
ts (R2) were N0.75 and pb0.05, except for the TT IgA mBc that were below the sensitivity
Fig. 2. Frequencies of mBc were determined by LDA and FCA (analyzing CD27+ and
CD27− mBc subsets together), as described in Figs. 1 and 3 respectively. (a) Total IgM,
IgG and IgA (n=11–14). (b) TT and (c) RV-speciﬁc IgM, IgG and IgA (n=8–10). Median
values are represented by a line. ⁎Signiﬁcant difference (Wilcoxon test, pb0.03).
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by LDA and FCA did not correlate (data not shown). Thus, results
with both assays differ quantitatively and qualitatively, and this
ﬁnding suggests that they measure overlapping but distinct pop-
ulations of mBc.
We next set to determine the relative contribution of each major
FCA mBc subset (CD27+/IgM+, CD27+/IgG/IgA+, CD27−/IgG/IgA+) to
total and Ag-speciﬁc mBc. For this analysis we considered the sum of
the three types of mBc as 100% of mBc (Figs. 4a and b). We found that
the percentage of RV-speciﬁc CD27−, IgG/IgA+ mBc was signiﬁcantly
higher than the percentage of total CD27−, IgG/IgA+ mBc (Wilcoxon
p=0.012) (Fig. 4a). This was not true for TT CD27−, IgG/IgA+ mBc.
Analysis of CD27−, IgG+ and CD27−, IgA+ mBc subsets independently
showed that the enrichment of RV-speciﬁc CD27−mBc depends on the
IgG isotype (Fig 4b). Recently, it has been determined that, when only
CD27+ mBc are considered, RV mBc are enriched in the IgD+, IgM+
subset (Tian et al., 2008). Performing a similar analysis in CD27+ cellsweobtained comparable results and thiswas not true for the TT CD27+,
IgM+ subset (Fig. 4c).
Thus, RV mBc are enriched in CD27−, IgG+ and in the CD27+, IgM+
mBc subsets. Of note, and as previously reported (Parez et al., 2004),
naive B cells (estimated as CD27−, IgM+ and CD27− IgG/IgA− Fig. 3b)
seem to be the predominant population of B cells that bind VLPs. RV
antigen does not seem to be unique in this aspect (Hangartner et al.,
2006; Parez et al., 2004; Ueki et al., 1990).
Correlation between mBc frequencies and plasma antibody levels
Trying to understand the relationship between mBc and serologic
memory, we determined if circulating mBc levels correlated with the
respective concentration of speciﬁc plasma Ig. The median (range) of
total and antigen speciﬁc plasma Ig concentrations of the individuals
studied is shown in Table 1. We did not measure antigen speciﬁc IgM
because we could not purify antigen speciﬁc Ig of this isotype to use as
a standard in the ELISA.
A correlationwas not observed between total IgM, IgG and IgAmBc
detected by either FCA (when CD27+ and CD27− were analyzed
together, or when either subpopulation was analyzed separately) or
LDA and the corresponding total plasma Ig level (data not shown). In
contrast, there was a signiﬁcant correlation between the frequency of
TT IgG mBc detected by LDA and the corresponding plasma antibody
levels (Fig. 5a). However, a correlation was not observed between TT
IgA mBc measured by LDA and TT plasma IgA (data not shown),
possibly because the levels of IgA mBc were below the level of
detection of the LDA in several volunteers. In addition, a correlation
was found between the frequency of RV IgAmBcmeasured by LDA and
RV plasma IgA level (Fig. 5a). This correlation was not found between
RV IgG mBc and RV plasma IgG (data not shown p=0.3 and R2=0.57).
For CD27+ mBc determined by FCA, we found a correlation between
the frequencies of TT IgG mBc and the plasma IgG level as well as
between RV IgA mBc and the respective plasma IgA RV antibody level
(Fig. 5b). However, when both CD27+ and CD27−mBcwere considered
together in the analysis, only the correlations between the frequency
of TT IgG mBc and the corresponding plasma antibody levels were
conserved (data not shown). Antigen speciﬁc CD27− mBc (analyzed
independently) did not correlate with plasma antibody levels (data
not shown).
The mean ratio of speciﬁc LDA mBc/μg/ml of the corresponding
plasma Ig was lower for TT IgG (73.3) than for RV IgA (693.6).
Similarly, the mean ratio of speciﬁc CD27+ FCA mBc/μg/ml of the
corresponding plasma Ig level was lower for TT IgG (116.46) than for
RV IgA (11,153). Thus, with both methods the ratio of speciﬁc IgA
mBc/plasma IgA concentration seems to be higher than the
corresponding IgG ratios.
Discussion
We have shown that RV mBc are enriched in the CD27+, IgM+
and in the CD27−, IgG+ mBc subsets. In addition, we found that the
frequencies of RV mBc measured by FCA are higher than those
measured by LDA, and shown that RV IgA mBc, quantiﬁed by both
assays, correlate with the concentrations of RV plasma IgA. To our
knowledge our study is one of the ﬁrst to study human circulating
antigen speciﬁc IgA mBc (Ueki et al., 1990), and the ﬁrst to show that
these cells correlate with IgA serological memory.
We found relatively high frequencies of RV mBc by FCA, (Fig. 2c),
and, as recently described (Tian et al., 2008), RV mBc were enriched
in the CD27+, IgM+ mBc subset (Fig. 4). Previous investigators have
reported similar frequencies of RV CD27+ mBc (∼5025/106 B cells) in
healthy adult volunteers (Parez et al., 2004). Unlike the RV IgD− mBc,
that are absent from naive mice (Youngman et al., 2002) and children
(Gonzalez et al., 2003), it is unknown if the RV-2/6-VLP binding IgM
mBcs we have detected in healthy adults are induced by prior RV
Fig. 3. Representative FCA dot plots of TT and RV-speciﬁc mBc from one volunteer. Puriﬁed B cells were gated on CD20+/CD27+ and on CD20+/CD27− subsets (left dot plot). On these
gates we performed: (a) Analysis of the expression of IgM+, IgG+, IgA+ on CD20+/CD27+mBc. (b) Analysis of the expression of IgM (naïve), IgG+ and IgA+(mBc) on CD20+/CD27− naive
B cells and mBc. The ﬁrst left dot plots in each row are controls stained with the anti-IgG antibody, and only streptavidin as a control for TT-biotin, and no antigen in the case of RV
VLPs. Numbers in each quadrant are the percentage of CD20+, CD27+ or CD27− B cells.
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2008). Against this possibility is our recent ﬁnding that these cells
seem to be present in children who do not have RV serum IgA, and
thus, by current standards, would be judged to have not been
previously infected by RV (Rojas et al., 2007). However, binding of the
RV-2/6-VLPs to IgM mBc is speciﬁc (inhibited with non labeled
antigen (Parez et al., 2004) and MF unpublished data), and antibodies
produced by cloned CD27+, IgD+ VLP binding B cells have been shown
to be VP6 speciﬁc (Tian et al., 2008). The binding of these antibodies
to VLPS is probably of low afﬁnity (Kallewaard et al., 2008), but is
probably not due to the fact that they are polyreactive, since IgM mBc
are not enriched (relative to the IgD− subset) in polyreactive mBc
(Tiller et al., 2007). We thus hypothesize that RV VP6, as presented on
VLPs, is a member of the group of viral antigens that bind an
important part of the repertoire of human Ig, probably as a means to
modulate the immune response (Hangartner et al., 2006). The role of
such antibodies in the antiviral response of humans has yet to be
deﬁned.
Very little is known of the CD27− mBc (Fecteau et al., 2006; Wei
et al., 2007; Wirths and Lanzavecchia, 2005). This is the ﬁrst time that
RV-speciﬁc CD27−mBc have been studied in detail. We found that the
correlation between RV CD27+, IgA mBc and RV plasma IgA levels was
lost when the analysis was done on RV CD27+ plus CD27− IgA cells and
RV plasma IgA (Fig. 5b). Moreover, the correlation between TT CD27+,
IgG mBc and TT plasma IgG (Fig. 5b) was slightly higher than when
CD27+ and CD27− subsets were analyzed together. These results
suggest that CD27− mBc (specially the RV IgA subset) are not directly
related to the levels of plasma Ig. Finally, our results showing little, ifany, TT CD27− mBc in our volunteers are in agreement with the
fact that TT antibodies are mainly of the IgG1 subclass, which is
not highly represented in the CD27−mBc (Fecteau et al., 2006; Wirths
and Lanzavecchia, 2005). The relatively high fraction of RV IgG and
IgA mBc in the CD27− subpopulation in adult volunteers is in agree-
ment with our previous study of RV mBc in recently infected chil-
dren (Jaimes et al., 2004). More studies, using recently described
markers (Wirths and Lanzavecchia, 2005), are needed to better
characterize this population of RV mBc and clarify their function in RV
infections.
The levels of total mBc detected by LDA (Fig. 2a) are comparable to
those reported by other groups (Amanna and Slifka, 2006; Lanza-
vecchia, 1983), and show a predominance of IgG, over IgM, over IgA.
The levels of total mBc detected by FCA are also comparable to those
reported by other groups (Johansson et al., 2005; Tian et al., 2007),
where a trend of predominance of IgM, over IgG, over IgA (Fig. 2a) was
observed. Moreover, mBc detected by LDA are lower than by FCA,
especially for IgM and IgA mBc (Fig. 2). Similar to total mBc, RV IgM
mBc were the predominant mBc detected by FCA, but RV IgG mBc
predominated by LDA. This is in contrast with the results with TT, for
which IgM mBc predominated by both methods. The discrepancies
between the two assays have been noted previously (Sasaki et al.,
2007) and could be due to at least two nonmutually exclusive reasons.
First, as noted previously under comparable conditions (He et al.,
2004; Lanzavecchia, 1983; Werner-Favre et al., 2001), it is possible
that IgM mBc are switching in vitro in the LDA to become IgG mBc.
Second, it seems possible that not all mBc detected by FCA can be
effectively stimulated by CpG/IL-2 to differentiate into ASC (Fig. 2).
Fig. 4. Frequencies (%) of mBc subsets considering (a) total mBc; (b) total and RV CD27−,
IgG+ and IgA+ mBc and (c) CD27+ mBc. ⁎Signiﬁcant differences (Wilcoxon test, pb0.05).
Median values are represented by a line.
Table 1
Plasma concentration (μg/ml) of total and antigen speciﬁc Ig
IgM IgG IgA
Total 1,367 (649–2,815) 7,390 (6,000–16,000) 1,262 (800–2,825)
RV ND 0.98 (0.4–3.9) 0.08 (0.013–0.35)
TT ND 1 (0.48–4.14) 0.02 (0.02–0.04)
ND: not determined. Shown is the median (range) of n=8–14 individuals.
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ubiquitous pathogen) represent a population of mBc that are more
susceptible to switching in vitro. On the other hand, the TT IgM mBc
probably represent cells that have not seen their cognate antigen for
many years and thus, they may be less prone to switch in vitro. In any
case, it seems that the functional LDA and non-functional FCAmeasure
overlapping, but partially distinct, subsets of mBc.
To our knowledge, this study is the ﬁrst to report a relationship
between antigen speciﬁc circulating IgA mBc and speciﬁc IgA levels in
plasma. Although RV infection and vaccination stimulate both
systemic and intestinal immune responses (Franco et al., 2006), it is
probable that the great majority of the RV plasma IgAwe measured in
healthy adults was produced by non-mucosal IgA secreting B cells,
since this IgA does not have a bound secretory component (data notshown) (Brandtzaeg, 2007). Because IgA and IgG ASC secrete similar
quantities of Ig (Lanzavecchia, 1983), the relatively higher mean ratio
of RV-speciﬁc IgA mBc per μg/ml of RV plasma IgA, compared to the
TT-speciﬁc IgG per mBc/μg/ml TT plasma IgG, could be explained by
the shorter half-life of IgA versus IgG (approximately 7 days for IgA vs.
20 days for IgG). Thus, circulating RV IgA mBc seem to have the same
relationship with plasma IgA as TT IgG mBc have with plasma IgG.
Altogether, these results suggest that in the steady state, most cir-
culating RV IgA mBc are systemically derived, and do not come from
the intestine. This interpretation is in agreement with the fact that in
healthy adults very few circulating IgA mBc express CCR9 (Johansson
et al., 2005), a key intestinal homing receptor, and the fact that RVmBc
that express CCR9 represent only 1/3 of speciﬁc mBc circulating
4 weeks after infection in children (Jaimes et al., 2004). In addition, it
has recently been shown that parenteral immunization, but not
intranasal immunization, with inﬂuenza vaccines induce circulating
speciﬁc mBc (Sasaki et al., 2007), also supporting the conclusion
that mBc in the circulation of healthy adults are predominantly
derived from systemic antigen exposure.
It has been proposed that mBc (continuously but non-speciﬁcally
stimulated to become ASC), recently activated short lived ASC, and
long lived bone marrow resident ASC maintain serological memory
(levels of speciﬁc serum Ig) (Hofer et al., 2006; Lanzavecchia et al.,
2006). Of note, we did not ﬁnd a correlation between the number of
circulating total IgM, IgG and IgA mBc and the corresponding levels
of plasma Ig (data not shown). We also did not ﬁnd a correlation
between total plasma IgG and IgA and circulating ASC evaluated by
ELISPOT in our volunteers (n=5) (data not shown). Hence, our results
suggest that bonemarrow resident ASC maybe an important source of
total plasma Ig in the steady state. However, certain subsets of
circulating antigen speciﬁc mBc (like TT IgG and RV IgA mBc) may also
be involved in directly maintaining serological memory, or indirectly
linked to this phenomenon, as they correlate with their respective
levels of plasma Ig (Fig. 5).
We used TT as a model antigen to compare with RV mBc, and in
general our results are in agreement with the literature: the frequency
of TT-speciﬁc IgG mBc evaluated by LDA (Fig. 2b) is similar to that
previously reported using alloreactive T cell clones (Lanzavecchia et
al., 1983), and CpG plus IL-2 (Bernasconi et al., 2002) for polyclonal B
cell stimulation. The frequency of IgG TT-speciﬁc mBc detected by FCA
is also comparable to previously reported results using a different FCA
(Amanna and Slifka, 2006; Leyendeckers et al., 1999). However, the
frequency of LDA TT-speciﬁc IgM mBc (Fig. 2b) is about 20 times
higher than the frequency previously reported (Lanzavecchia et al.,
1983) using alloreactive T cell clones as a stimulus. In addition,
previous studies using FCA (Leyendeckers et al., 1999) found that most
(68%) TT mBc expressed IgG and not IgM, as opposed to our ﬁndings
(Fig. 2b). We do not have a clear explanation for these discrepancies.
However, it is possible that in the case of the LDA, alloreactive clones
are less efﬁcient than CpG/IL-2 at stimulating TT IgM mBc. On the
other hand, the mBc detected by the TT Fragment C (an immunodo-
minant recombinant fragment of TT), used previously by other authors
(Leyendeckers et al., 1999), could be recognizing a different population
of TT mBc than the complete TT antigen used in our study. The
correlation between TT IgG mBc measured by LDA and the levels of
TT IgG in plasma (Fig. 5) is in agreement with previous ﬁndings
(Bernasconi et al., 2002). Of note, these results do not necessarily
Fig. 5. Correlations between plasma antibody concentrations and frequency of mBc. (a) Signiﬁcant correlations were found between TT-speciﬁc IgG or RV-speciﬁc IgA mBc
determined by LDA and their corresponding TT-speciﬁc IgG, and RV-speciﬁc IgA levels in plasma (n=8–10, Spearman test, pb0.01). (b) Signiﬁcant correlations were found between
plasma antibody levels and the frequency of CD27+mBc detected by FCA for TT-speciﬁc IgG and RV-speciﬁc IgA (n=8, Spearman test, pb0.04). After Bonferroni correction for multiple
comparisons the correlations between LDA, but not FCA mBc, and plasma Ig are still signiﬁcant (pb0.01).
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lation was not found, but in which the concentration of plasma TT IgG
was measured as a titer and not in μg/ml, as we have done. However,
the correlation between TT IgG mBc determined by FCA and TT IgG in
plasma (Fig. 5b) is not in agreement with other previous ﬁndings
(Leyendeckers et al., 1999), probably due to differences in the cell
staining method, and as mentioned previously, the fact that the TT
antigen used in the previous study was different from the preparation
used here. The relatively low levels of TT-speciﬁc IgA mBc we found
are compatiblewith the levels of TT IgA ASC induced by TT vaccination
(Lue et al., 1994).
In conclusion, we have shown that RV mBc are enriched in CD27+,
IgM+ and CD27−, IgG+ mBc (Fig. 4) and that circulating RV-speciﬁc IgA
mBc (evaluated by both FCA and LDA) correlate with plasma RV IgA
concentration. Future studies are necessary to clarify the relationship
between the two mBc assays, and to better characterize the CD27+,
IgM+ and CD27−, IgG+ RV mBc. Moreover, our studies contribute to
understand the relationship between circulating mBc and serological
memory, and enhance our capacity to develop better correlates of
protection against RV disease. We recently published the results of a
clinical trial in which we hypothesized that IgD− RV mBc that express
the intestinal homing receptor CCR9 correlatewith protection induced
by the Rotarix vaccine (Rojas et al., 2007). However, this correlation
was poor and the correlations between the frequencies of mBc in the
vaccine recipients and their plasma IgA levels were low or non-
existent. Possible explanations for these ﬁndings are multiple and
include the fact that RV mBc are a heterogeneous group of cells and
that these numerous groups are related to RV plasma Ig in different
ways. The new information provided in the present manuscript and
complimentary results (Narváez et al., manuscript in preparation)
support this conclusion and should permit us to focus on speciﬁc mBc
subsets in our future studies with children to identify correlates of
protection for RV vaccines.Materials and methods
Subjects and sample collection processing
Peripheral blood mononuclear cells (PBMC) were isolated from
the buffy coats obtained from 19 healthy adult blood donors by
density gradient centrifugation using Lymphosep (ICN Biomedical INC,
Irvine, CA). Cells were suspended in complete RPMI-1640 supple-
mented with 10% fetal calf serum, 20 mM HEPES, 100 U/ml
penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine, 0.1 mM of
non essential amino acids and 1 mM of sodium pyruvate (all from
Gibco-BRL, Gaithersburg, Md) and 5×10-5 M of β-mercaptoethanol
(Sigma-Aldrich, Saint Louis, Missouri). Cells were washed twice with
complete medium and directly tested in the LDA or FCA. From each
volunteer, an additional blood sample was collected in heparin-
containing tubes and centrifuged at 250 ×g for 5 min and the plasma
was collected and stored at −20 °C.
Production of ﬂuorescent virus like particles (VLPs)
Fluorescent RV VLPs were a kind gift of Annie Charpilienne and
were produced using baculovirus expression vectors, as previously
described (Charpilienne et al., 2001). Brieﬂy, Sf9 cells were co-
infected with 2 recombinant baculoviruses at a multiplicity of
infection greater than 5 PFU/cell. One baculovirus expressed RF
(bovine RV) VP6 and the other a fusion protein consisting of GFP
fused to the N terminus of RF VP2 deleted in the ﬁrst 92 amino acids.
Infected cultures were collected 5–7 days post infection and puriﬁed
by density gradient centrifugation in CsCl. The protein concentra-
tion in the puriﬁed VLPs was estimated by the method of Bradford.
The VP6 protein on the outer shell of the VLPs is recognized by
the majority of RV antibodies in infected animals and humans
(Youngman et al., 2002).
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TT (Staten Serum Institute, Denmark) was resuspended according
to the manufacturer's instructions, and biotinylated using the EZ-Link
Photoactivatable Biotin kit (Pierce Biotechnology, Rockford, IL) accord-
ing to manufacturer's protocol. Brieﬂy, 750 μg of TT protein was
incubated with biotin at a molar ratio of 20 mol of dye per mole of
protein, for 10min on ice under a UV (365 nm) lamp and then dialyzed
against PBS to remove excess biotin. The optimal concentration of the
biotinylated TT for labeling of speciﬁc mBc was determined using
PBMC from healthy and recently TT vaccinated volunteers, and the
speciﬁcity of binding was evaluated with a competition assay using
non biotinylated TT (data not shown).
Flow cytometry assay
Fresh PBMC were washed once with PBS containing 2 mM EDTA
(Sigma-Aldrich), 10% fetal calf serum and then incubated with anti
CD19 microbeads (Miltenyi Biotec, Auburn, CA). Immunomagnetic
positive selection of CD19+ cells was done according to the manufac-
turer's instructions. The B cells were over 90% pure. The CD19+ B cells
were incubated with the GFP labeled VLPs (0.8 μg/test), TT-biotin
(5 μg/test) or without any reagent (negative control) for 45 min in the
dark, at 4 °C. The cells were thenwashed with PBS–0.5% bovine serum
albumin (Sigma-Aldrich), 0.02% sodium azide (Mallinckrodt Chemi-
cals, Paris, Ky) (staining buffer) and stained with antibodies against
CD20 (allophycocyanin labeled), CD27 (phycoerythrin labeled) (BD
Pharmingen, La Jolla, CA) and anti-IgG, IgA, IgM (ﬂuorescein isothio-
cianate labeled) (Caltag Laboratories, Burlingame, CA) or anti IgA,
IgM-biotin (Kirkegaard and Perry Labs, Gaithersburg, MD) or IgG-
biotin (Jackson Immunoresearch, West Grove, PA). The biotinylated
antigen or antibodies were detected using streptavidin-PerCP (BD
Pharmingen). After staining, the cells were washed with staining
buffer and ﬁxed with 1% paraformaldehyde (Electron Microscopy
Sciences, Washington, PA). At least 800,000 puriﬁed B cells were
acquired on a FACSCalibur (BD Pharmingen) and the data was ana-
lyzed with Cellquest Pro software version 2.1. The estimated limit of
detection for antigen speciﬁc mBc by FCA was ∼30 cells/106 B cells,
values below this number were assigned a value of 15 cells/106 B cells
for statistical purposes.
Limiting Dilution Assay (LDA)
LDA was performed using PBMC or puriﬁed B cells. For most
experiments to determine frequencies of RV mBc, and all experiments
to evaluate total and TT mBc, PBMC were stimulated using previously
describedmethods (Bernasconi et al., 2002). PMBCwere distributed in
serial dilutions from 200,000 to 5 cells in a volume of 200 μl per well
using 24 replicate cultures per dilution on 96 U wells culture plates
(Costar). Cells were stimulated with 2.5 μg/ml of CpG oligodeoxynu-
cleotide 2006 (Microsynth, Switzerland) and 10 ng/ml of human
recombinant IL-2 (R&D systems, Minneapolis, MN) for 10 days at
37 °C/5% CO2. PBMC without stimulation were used as a negative
control and analysis of TT mBc was used as a positive control. After
10 days the plates were centrifuged and the supernatants were stored
at −20 °C. The supernatants from the 24 replicate cultures were
thawed and tested for the presence of total Ig, RV or TT-speciﬁc IgG,
IgA and IgM by ELISA. The number of PBMC per culture was plotted
against the natural logarithm of the fractions of negative cultures for
each Ig, as previously described (Lanzavecchia, 1983). Least-squares
linear regressionwas used to ﬁt a linewith the different frequencies of
negative cultures and the origin. The R2 (N0.75) and p-value (pb0.05)
were calculated for each best ﬁtting line. The frequency of mBc
producing total or speciﬁc antibodies were calculated from the 37%
interpolation of the titration curve, that according to the Poisson
distribution represents the number of wells containing a singleprecursor. The frequency of CD20+ cells in fresh PBMC of each
volunteer (determined by FCA) was used to express ﬁnal results in
terms of mBc/total B cells. The estimated limit of detection for anti-
gen speciﬁc mBc by LDA was ∼28 mBc/106 B cells and values below
this limit were assigned a value of 14.2/106 B cells for statistical
purposes.
In some LDA experiments PBMC were stimulated, as previously
described (Crotty et al., 2004; Sasaki et al., 2007), with CpG (6 μg/ml),
1/10,000 dilution of ﬁxed Staphylococcus aureus Cowan (SAC) (Sigma-
Aldrich) and 1/100,000 dilution of pokeweed mitogen extract (SAC
and PWM, were kindly provided by Dr. R. Ahmed, Emory University,
Atlanta, GA) and cultured as described above.
For LDA with puriﬁed B cells, CD19+ cells were positively puriﬁed
(purityN94%) using microbeads (Miltenyi Biotec). B cells were
distributed in serial dilutions from 50,000 to 325 cells in a volume
of 200 μl per well, using 24 replicate cultures per dilution in 96 U well
culture plates and stimulated with CpG+IL-2 (Bernasconi et al., 2002),
CpG+SAC+PWM (Crotty et al., 2004) (as described above for the
PBMC), CpG+IL-2 plus puriﬁed autologous CD4+ T cells, and CpG+
IL-2/IL-6/IL-10 plus NIH/3T3 murine ﬁbroblasts (Amanna and Slifka,
2006). For the last condition 10 ng/ml of hrIL-6 (R&D, Minneapolis,
MN) and 15 ng/ml of hrIL-10 (from Pharmingen) were used. The
feeder cells for the last two conditions (microbead (Miltenyi Biotec)
positively selected autologous CD4+ T cells (purityN98%) and NIH/3T3
murine ﬁbroblasts (a gift from E. Butcher, Stanford University CA),
respectively) were treated with 50 μg/ml of mitomycin C (Sigma-
Aldrich) for 30 min, washed exhaustively and then used at 5000 cells/
well. After 10 days of culture, the supernatants were collected to
evaluate RV IgM/IgG/IgA by ELISA, as described below.
ELISA for measuring RV and TT-speciﬁc antibodies and total Ig in plasma
and LDA culture supernatants
Antigen speciﬁc IgA, IgG and IgM were determined in plasma and
culture supernatants by ELISA, as previously described (Gonzalez
et al., 2003; Lanzavecchia et al., 1983), with some modiﬁcations. For
total IgG, IgA, IgM, TT-speciﬁc IgG, IgA, IgM and RV-speciﬁc IgG and
IgA, Immulon 2 ELISA plates (DYNEX Technologies, Chantilly, VA)
were coated with appropriate concentrations of anti whole Ig (Sigma-
Aldrich), TT, VLPs, or PBS (negative control) and incubated overnight
at 4 °C. After discarding these solutions, 150 μl 5% blotto was added
to the plates and incubated at 37 °C for 1 h. Then, the blotto was
discarded and 70 μl of the dilutions of plasma in 2.5% blotto or the
culture supernatants were deposited in each well. After 2 h incuba-
tion at 37 °C, the plates were washed three times with PBS-Tween 20
and 70 μl of biotin-labeled goat anti-human IgA, IgG or IgM
(Kirkegaard and Perry Labs) diluted in 2.5% blotto was added and
incubated for 1 h at 37 °C. After three washes with PBS-Tween, 70 μl
streptavidin-peroxidase (Kirkegaard and Perry Labs) 1/1000 dilution
in 2.5% blottowas added and the plates were incubated for 1 h at 37 °C.
After three washes with PBS-Tween 20, plates were developed using
70 μl tetramethyl benzidine substrate (TMB, Kirkegaard and Perry
Labs). The reaction was stopped by the addition of 17.5 μl of 2 M
sulfuric acid. Absorbance was read at a wave length of 450 nm on an
ELISA plate reader.
For detection of RV-speciﬁc IgM, 96 well plates were coated
overnight with 70 μl of Goat F(ab′)2 (0.7 μg/well) anti-human IgM
(Biosource International, Camarillo, CA). The plates were then blocked
and incubated with plasma or supernatant culture samples, as des-
cribed above. After three washes with PBS-Tween 20, 70 μl of VLPs
(16 ng/well) were added to individual wells and incubated for 1 h at
37 °C. Plates were then washed and guinea pig anti-rhesus RV
hyperimmune serum was added and incubated for 1 h at 37 °C. After
three washes, 70 μl of biotin-labeled goat anti-guinea pig (Vector
Laboratories, Burlingame, CA) in 2.5% blotto-1.5% normal goat serum
was added and incubated for 1 h at 37 °C. After three washes with
241O.L. Rojas et al. / Virology 380 (2008) 234–242PBS-Tween, 70 μl streptavidin-peroxidase was added, and ﬁnally, the
assay was developed as described above.
A standard curve was constructed using known amounts of puriﬁed
total IgG, IgA (Sigma-Aldrich) and puriﬁed RV-speciﬁc IgG and IgA or
TT-speciﬁc IgG and IgA. The antigen speciﬁc Igs were puriﬁed using a
CarboxyLink kit (Pierce Biotechnology). Brieﬂy, RV-DLPs or TT antigen,
were ﬁxed to the column and the puriﬁed IgG or IgA (Sigma-Aldrich)
bound to the antigens and latter eluted from the columns according to
manufacturer's instructions. Ig concentrations in plasma were calcu-
lated using the program ELISA forWindows, Version 2.00 (http://www.
cdc.gov/ncidod/dbmd/bimb/elisa.htm). The limits of detection for each
plasma ELISA were as follows: 3 ng/ml for total IgA, 4 ng/ml for total
IgG, 12.5 ng/ml for RV IgA, 46 ng/ml for RV IgG, 20 ng/ml for TT IgA and
52 ng/ml for TT IgG. The puriﬁed RV IgG and IgA did not recognize TT
and the puriﬁed TT IgG and IgA did not recognize RV (data not shown).
The culture supernatants assayed by ELISA were scored as positive
if they had an optical density exceeding 0.1 and the optical densitywas
twice the optical density of wells treated with PBS. We used standard
serial dilutions of known plasma as a positive control in each plate. To
be accepted for analysis, the titer of the positive control plasma in a
plate could not differ by more than one dilution from plate to plate.
Statistical analysis
Analysis was performedwith SPSS software version 10.0 (SPSS Inc.,
Chicago, IL). Differences between groups were evaluated with a
Wilcoxon test, and correlations between the different variables
were evaluated with two tailed Spearman's tests. Signiﬁcance was
established if p≤0.05. Data are shown as medians and ranges unless
otherwise noted.
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